黑料网

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Awards & Nominations
PMC/PubMed Indexed Articles

Publication Policies and Ethics
Citations : 790

Flyer image
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
View More
Useful Links
Recommended Journals
View More
Related Subjects
View More
Share This Page

Biomarker Discovery

Biomarker discovery involves identifying biological markers—molecules found in blood, other body fluids, or tissues—that indicate the presence or progression of a disease, or the effects of a treatment. These biomarkers can help in diagnosing diseases, predicting outcomes, and monitoring therapeutic responses.
Biomarker discovery is crucial for advancing precision medicine by providing insights into disease mechanisms and treatment effects. It involves techniques such as genomics, proteomics, and metabolomics to find novel biomarkers that can be used for early diagnosis, personalized treatment plans, and monitoring disease progression.

Biomarker Discovery

Expert PPTs

Speaker PPTs

  • Joachim Struck
    Pro-enkephalin (Penkid): A novel plasma biomarker to assess renal impairment
    | PDF Version
  • Saroj Velamakanni
    Multiparameter analysis using cell cycle biomarkers for breast cancer: Prognostic and predictive implications
    | PDF Version
  • Hamiyet Unal
    Constitutive activity in the angiotensin ii type 1 receptor: Discovery and applications
    | PDF Version
  • Sergey Suchkov
    Translational tools as applicable to autoimmune disorders: antibody-proteases as a generation of highly informative and unique biomarkers to monitor subclinical and clinical stages of demyelination in multiple sclerosis (MS)
    | PDF Version
  • Adel Nefzi
    脙垄芒聜卢脜聯Adel Nefzi-Torrey-Pines-Institute-for-Molecular-Studies-USA-Diversity-Oriented-Synthesis-of-low-Molecular-Weight-Acyclic-and-Heterocyclic-Compounds-from-Resin-bound-Polyamides-Application-for-Drug-Discovery脙垄芒聜卢脗聺
    | PDF Version
  • Lei Huo
    Diagnostic biomarkers in metastatic breast cancer
    | PDF Version
  • Amila Orucevic
    Prognostic value of ER, PR, and HER2 breast cancer biomarkers and AJCC脙垄芒聜卢芒聞垄s TNM staging system on overall survival of Caucasian females with breast cancer: An institution脙垄芒聜卢芒聞垄s 10 year experience
    | PDF Version
  • Kirill Shlyapnikov
    Fibromyalgia and chronic fatigue syndrome (CFS): translational biomarkers as applicable to monitor and to predict clinical manifestations
    | PDF Version
  • Sungchul Ji
    Mathematical Models of RNA Expression Profiles: Potential Applications to Drug Discovery Research and Personalized Medicine
    | PDF Version
  • Soo-Young Yoon
    Isocitrate dehydrogenase 1 (IDH1) mutation-specific twelve microRNA signatures as prognostic biomarkers in acute myeloid leukemia
    | PDF Version
  • Diana A.T. Nijholt
    PZP: A novel biomarker for early Alzheimer脙垄芒聜卢芒聞垄s disease ?
    | PDF Version
  • Mark D Gorrell
    The protease fibroblast activation proteinas a biomarker and therapeutic target in cancer and chronic liver injury
    | PDF Version
  • Subbu Apparsundaram
    Biomarkers and pharmacogenomics in CNS disorders
    | PDF Version
  • Loui Madakamutil
    Discovery of a small molecule inhibitor of Burton脙垄芒聜卢芒聞垄s Tyrosine Kinase(BTK) for Loui Madakamutil, Ph.D 0 autoimmune diseases
    | PDF Version
  • Bairong Shen
    Computational biomarker discovery in the big data era: From translational biomedical informatics to systems medicine
    | PDF Version
  • K.V. Ovsyannikov
    K.V. Ovsyannikov
    | PDF Version
  • Huseyin Cimen
    Discovery-based Targeted Proteomic Studies: Gel-based and/or off-gel protein sample preparation and purification
    | PDF Version
  • Wancai Yang
    Wancai Yang
    | PDF Version
  • Youhe Gao
    Youhe Gao
    | PDF Version
  • James Hendrix
    Discovery of a first-in-class topically bioavailable kit inhibitor with clinical activity using computational chemogenomics technology
    | PDF Version
  • Fatih Yalcin
    EARLY IMAGING BIOMARKER IN REMODELING DUE TO HEART FAILURE
    | PDF Version
  • Pollen K F Yeung
    ATP Metabolism as Biomarker Target for Cardiovascular Protection and Toxicity
    | PDF Version
  • Samuel C Dudley
    Novel biomarkers for diastolic heart failure
    | PDF Version
  • Praveen Thaggikuppe Krishnamurthy
    Newer approaches to the discovery of glitazones
    | PDF Version
Conference Proceedings